Skip to main content
. 2020 Dec 1;76(3):653–658. doi: 10.1093/jac/dkaa499

Table 2.

Discrepancy rates of VITEK 2 compared with broth microdilution for Elizabethkingia spp.a,b

Agent Total (n = 108)
E. anophelis (n = 90)
E. meningoseptica (n = 7)
E. miricola cluster (n = 11)c
MD VMD MD VMD MD VMD MD VMD
Amikacin 12.1 0 5.6 0 0 0 72.7 0
Ampicillin/sulbactam 0 0 0 0 0 0 0 0
Cefepime 0.9 0 1.1 0 0 0 0 0
Cefotaxime 0 0 0 0 0 0 0 0
Ceftazidime 0 0 0 0 0 0 0 0
Ciprofloxacin 0 8.3 0 8.9 0 0 0 9.1
Colistin 0 0 0 0 0 0 0 0
Gentamicin 0 0 0 0 0 0 0 0
Imipenem 0 0 0 0 0 0 0 0
Levofloxacin 0 0.9 0 1.1 0 0 0 0
Meropenem 0 0 0 0 0 0 0 0
Minocycline 0.9 0 0 0 0 0 9.1 0
Moxifloxacin 0.9 5.6 0 6.7 0 0 9.1 0
Piperacillin/tazobactam 6.5 0 3.3 0 14.3 0 27.3 0
Rifampin 0 0 0 0 0 0 0 0
Tigecycline 11.1 0 7.8 0 42.9 0 18.2 0
Trimethoprim/sulfamethoxazole 45.4 0 50 0 57.1 0 0 0
Vancomycin 0 3.7 0 1.1 0 14.3 0 18.2
a

Data are presented as percentages (%).

b

MD rates of >3.0% or VMD rates of >1.5% are underlined.

c

E. miricola cluster comprised E. miricola (6), E. bruuniana (3) and E. ursingii (2); no E. occulta isolates were identified.